Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 625 of 3546 entries
View as:

Safety Study Using GSK573719 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT00515502 Org: User:
Start: 06/21/07 End: 11/06/07 Due: 11/06/08

Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT00347009 Org: User:
Start: 05/31/05 End: 09/30/09 Due: 09/30/10

Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02502812 Org: User:
Start: 09/04/15 End: 09/24/15 Due: 09/24/16

Oral and Dermal Tolerability Clinical Study of an Experimental Denture Wipe

Phase: N/A Priority: Normal
NCT ID: NCT03478644 Org: User:
Start: 10/10/16 End: 10/31/16 Due: 10/31/17

Phase I Study of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00516672 Org: User:
Start: 09/10/07 End: 10/14/15 Due: 10/14/16

A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00555139 Org: User:
Start: 03/27/07 End: 01/10/08 Due: 01/10/09

Month 30 & 42 Extension Studies of CRD-004 Primary Study

Phase: N/A Priority: Normal
NCT ID: NCT00492648 Org: User:
Start: 06/25/07 End: 06/23/08 Due: 06/23/09

Study to Estimate the Burden of Herpes Zoster and Postherpetic Neuralgia in Spain

Phase: N/A Priority: Normal
NCT ID: NCT01521286 Org: User:
Start: 03/31/12 End: 05/31/15 Due: 05/31/16

Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule

Phase: N/A Priority: Normal
NCT ID: NCT00291876 Org: User:
Start: 01/01/04 End: 03/01/13 Due: 03/01/14

Study to Assess the Efficacy and Safety of Potassium Clavulanate/Amoxicillin in Children With Acute Bacterial Rhinosinusitis

Phase: N/A Priority: Normal
NCT ID: NCT01934231 Org: User:
Start: 08/30/13 End: 11/07/13 Due: 11/07/14

Assessment of Lung Function After Single Inhalations of a Bronchodilator From 2 Configurations a Dry Powder Inhaler.

Phase: N/A Priority: Normal
NCT ID: NCT01521390 Org: User:
Start: 10/12/11 End: 12/16/11 Due: 12/16/12

Dose Response of a Tubule Occlusion Agent

Phase: N/A Priority: Normal
NCT ID: NCT01075256 Org: User:
Start: 12/31/08 End: 03/31/09 Due: 03/31/10

A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers

Phase: N/A Priority: Normal
NCT ID: NCT04605159 Org: User:
Start: 11/20/20 End: 06/14/23 Due: 06/14/24

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK1278863A in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00750256 Org: User:
Start: 07/07/08 End: 12/12/08 Due: 12/12/09

Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01077531 Org: User:
Start: 04/28/10 End: 03/19/13 Due: 03/19/14

A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06567782 Org: User:
Start: 02/17/25 End: 06/15/28 Due: 06/15/29

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06710847 Org: User:
Start: 12/13/24 End: 06/16/28 Due: 06/16/29

Study in Neuropathic Pain Patients With Peripheral Nerve Injury

Phase: N/A Priority: Normal
NCT ID: NCT00969059 Org: User:
Start: 08/31/09 End: 07/31/10 Due: 07/31/11

Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00524576 Org: User:
Start: 11/28/07 End: 05/14/08 Due: 05/14/09

An Open Label, Randomised, Repeat Dose Study to Assess the Pharmacokinetic Performance of Five Ezogabine/Retigabine Modified Release (MR) Formulations at Steady State Compared to the Immediate Release (IR) Formulation.

Phase: N/A Priority: Normal
NCT ID: NCT01332513 Org: User:
Start: 02/10/11 End: 05/23/11 Due: 05/23/12

Evaluation of Umeclidinium Bromide in Combination With Fluticasone Furoate in COPD Subjects With an Asthmatic Component

Phase: N/A Priority: Normal
NCT ID: NCT02164539 Org: User:
Start: 07/01/14 End: 07/18/15 Due: 07/18/16

A Study to Compare the Safety and Drug Levels in Blood When Using Various Forms of GSK189075 Given to Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00559884 Org: User:
Start: 11/30/07 End: - Due: -

Bioequivalence Minocycline Bioequivalence

Phase: N/A Priority: Normal
NCT ID: NCT01755611 Org: User:
Start: 06/17/11 End: 06/25/11 Due: 06/25/12

Lapatinib in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00477464 Org: User:
Start: 06/30/07 End: 12/31/10 Due: 12/31/11

A First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of GSK189075A in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01571661 Org: User:
Start: 09/30/04 End: 01/31/05 Due: 01/31/06